MX2009006653A - Composicion de liberacion prolongada y metodo para producirla. - Google Patents
Composicion de liberacion prolongada y metodo para producirla.Info
- Publication number
- MX2009006653A MX2009006653A MX2009006653A MX2009006653A MX2009006653A MX 2009006653 A MX2009006653 A MX 2009006653A MX 2009006653 A MX2009006653 A MX 2009006653A MX 2009006653 A MX2009006653 A MX 2009006653A MX 2009006653 A MX2009006653 A MX 2009006653A
- Authority
- MX
- Mexico
- Prior art keywords
- sustained
- physiologically active
- producing
- same
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Nanotechnology (AREA)
- Pregnancy & Childbirth (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87536406P | 2006-12-18 | 2006-12-18 | |
US91740107P | 2007-05-11 | 2007-05-11 | |
PCT/JP2007/074617 WO2008075762A1 (en) | 2006-12-18 | 2007-12-17 | Sustained-release composition and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009006653A true MX2009006653A (es) | 2009-07-02 |
Family
ID=39015849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009006653A MX2009006653A (es) | 2006-12-18 | 2007-12-17 | Composicion de liberacion prolongada y metodo para producirla. |
Country Status (27)
Country | Link |
---|---|
US (3) | US8921326B2 (de) |
EP (1) | EP2094246B1 (de) |
JP (2) | JP4564098B2 (de) |
KR (1) | KR101522035B1 (de) |
CN (1) | CN101563068B (de) |
AR (1) | AR064381A1 (de) |
AU (1) | AU2007335406B2 (de) |
BR (1) | BRPI0720582B1 (de) |
CA (1) | CA2671670C (de) |
CL (1) | CL2007003658A1 (de) |
CO (1) | CO6180498A2 (de) |
CR (1) | CR10867A (de) |
DO (1) | DOP2009000144A (de) |
EA (1) | EA016176B1 (de) |
EC (1) | ECSP099439A (de) |
ES (1) | ES2791698T3 (de) |
GE (1) | GEP20125597B (de) |
IL (1) | IL198845A (de) |
MA (1) | MA31006B1 (de) |
MX (1) | MX2009006653A (de) |
MY (1) | MY148370A (de) |
NO (1) | NO347209B1 (de) |
NZ (1) | NZ577281A (de) |
PE (1) | PE20081842A1 (de) |
TN (1) | TN2009000197A1 (de) |
TW (1) | TWI481424B (de) |
WO (1) | WO2008075762A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI481424B (zh) | 2006-12-18 | 2015-04-21 | Takeda Pharmaceutical | 緩釋性組成物及其製法 |
SG181436A1 (en) * | 2009-12-22 | 2012-07-30 | Takeda Pharmaceutical | Sustained-release formulation |
EA021663B1 (ru) * | 2010-06-25 | 2015-08-31 | Такеда Фармасьютикал Компани Лимитед | Композиция с замедленным высвобождением, способ ее получения и способ лечения рака |
EP2842545B1 (de) * | 2012-04-24 | 2020-02-12 | Osaka University | Verfahren zur herstellung einer wässrigen dispersion aus arzneimittelnanopartikeln und verwendung davon |
KR101558083B1 (ko) * | 2014-04-07 | 2015-10-07 | 에스케이케미칼주식회사 | 약물함유 고분자미립구 제조방법 |
US9956164B2 (en) | 2014-04-16 | 2018-05-01 | Veyx-Pharma Gmbh | Veterinary pharmaceutical composition and use thereof |
TW201618783A (zh) | 2014-08-07 | 2016-06-01 | 艾森塔製藥公司 | 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法 |
CA3077011A1 (en) * | 2017-09-26 | 2019-04-04 | Nanomi B.V. | Method for preparing micro-particles by double emulsion technique |
KR101936040B1 (ko) * | 2018-04-23 | 2019-01-08 | 주식회사 씨트리 | 안정화된 단상 혼합액을 이용하는 생분해성 미립구의 제조방법 |
CN112955181A (zh) | 2019-03-26 | 2021-06-11 | 新型医药公司 | 一种长效脂肪酸缀合的GnRH衍生物及含其的药物组合物 |
CA3143471C (en) * | 2019-07-12 | 2023-10-31 | Heeyong Lee | Long-lasting formulation containing rivastigmine, and method for preparing same |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3297033A (en) | 1963-10-31 | 1967-01-10 | American Cyanamid Co | Surgical sutures |
US3565869A (en) | 1968-12-23 | 1971-02-23 | American Cyanamid Co | Extrudable and stretchable polyglycolic acid and process for preparing same |
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US3755558A (en) | 1971-02-23 | 1973-08-28 | Du Pont | Polylactide drug mixtures for topical application atelet aggregation |
US3839297A (en) | 1971-11-22 | 1974-10-01 | Ethicon Inc | Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures |
US3912692A (en) | 1973-05-03 | 1975-10-14 | American Cyanamid Co | Process for polymerizing a substantially pure glycolide composition |
US3890283A (en) | 1973-06-04 | 1975-06-17 | American Cyanamid Co | Process for post-polymerizing polyglycolic acid |
US4258063A (en) | 1978-06-23 | 1981-03-24 | Henkel Corporation | Self-emulsifying cosmetic base |
US4249531A (en) | 1979-07-05 | 1981-02-10 | Alza Corporation | Bioerodible system for delivering drug manufactured from poly(carboxylic acid) |
US4273920A (en) | 1979-09-12 | 1981-06-16 | Eli Lilly And Company | Polymerization process and product |
PH19942A (en) | 1980-11-18 | 1986-08-14 | Sintex Inc | Microencapsulation of water soluble polypeptides |
US5366734A (en) | 1981-02-16 | 1994-11-22 | Zeneca Limited | Continuous release pharmaceutical compositions |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
US4479911A (en) | 1982-01-28 | 1984-10-30 | Sandoz, Inc. | Process for preparation of microspheres and modification of release rate of core material |
US4605730A (en) | 1982-10-01 | 1986-08-12 | Ethicon, Inc. | Surgical articles of copolymers of glycolide and ε-caprolactone and methods of producing the same |
US4539981A (en) | 1982-11-08 | 1985-09-10 | Johnson & Johnson Products, Inc. | Absorbable bone fixation device |
FR2537980B1 (fr) | 1982-12-17 | 1986-12-19 | Sandoz Sa | Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation |
CH656884A5 (de) | 1983-08-26 | 1986-07-31 | Sandoz Ag | Polyolester, deren herstellung und verwendung. |
JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
JPH0678425B2 (ja) | 1984-07-06 | 1994-10-05 | 和光純薬工業株式会社 | 重合体の新規製造法 |
CA1256638A (en) | 1984-07-06 | 1989-06-27 | Motoaki Tanaka | Polymer and its production |
ATE61935T1 (de) | 1985-02-07 | 1991-04-15 | Takeda Chemical Industries Ltd | Verfahren zur herstellung von mikrokapseln. |
JP2551756B2 (ja) | 1985-05-07 | 1996-11-06 | 武田薬品工業株式会社 | ポリオキシカルボン酸エステルおよびその製造法 |
JP2653255B2 (ja) | 1990-02-13 | 1997-09-17 | 武田薬品工業株式会社 | 長期徐放型マイクロカプセル |
MY107937A (en) * | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
FR2658432B1 (fr) | 1990-02-22 | 1994-07-01 | Medgenix Group Sa | Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation. |
DE69129770T2 (de) | 1990-04-13 | 1998-11-19 | Takeda Chemical Industries Ltd | Biologisch abbaubare hochmolekulare Polymere, ihre Herstellung und ihre Verwendung |
JP3116311B2 (ja) | 1990-06-13 | 2000-12-11 | エーザイ株式会社 | マイクロスフィアの製法 |
FR2693905B1 (fr) | 1992-07-27 | 1994-09-02 | Rhone Merieux | Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues. |
ATE161716T1 (de) | 1992-08-07 | 1998-01-15 | Takeda Chemical Industries Ltd | Herstellung von mikrokapseln, die wasserlösliche arzneimittel enthalten |
JP3277342B2 (ja) | 1992-09-02 | 2002-04-22 | 武田薬品工業株式会社 | 徐放性マイクロカプセルの製造法 |
TW333456B (en) | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
DE4342092B4 (de) | 1993-12-09 | 2007-01-11 | Zentaris Gmbh | Langwirkende Injektionssuspension und Verfahren zur Herstellung |
JP3490171B2 (ja) | 1994-02-21 | 2004-01-26 | 武田薬品工業株式会社 | 生体内分解性ポリマーの末端カルボキシル基におけるエステル |
CA2143044C (en) | 1994-02-21 | 2005-04-12 | Yasutaka Igari | Matrix for sustained-release preparation |
JPH07273447A (ja) | 1994-03-29 | 1995-10-20 | Sumitomo Kinzoku Ceramics:Kk | セラミック回路基板及びその製造方法 |
US5763513A (en) | 1994-05-19 | 1998-06-09 | Mitsui Toatsu Chemicals, Inc. | L-lactic acid polymer composition, molded product and film |
FR2736508B1 (fr) | 1995-07-13 | 1997-09-19 | Francais Prod Ind Cfpi | Nouvelle forme solide de stockage et de commercialisation pour compositions phytosanitaires et moyens pour sa preparation |
TW448055B (en) | 1995-09-04 | 2001-08-01 | Takeda Chemical Industries Ltd | Method of production of sustained-release preparation |
CA2192782C (en) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
CA2192773C (en) | 1995-12-15 | 2008-09-23 | Hiroaki Okada | Production of sustained-release preparation for injection |
DK0839525T3 (da) | 1996-10-31 | 2004-11-29 | Takeda Pharmaceutical | Præparat med forlænget frigivelse |
JPH10273447A (ja) | 1997-01-29 | 1998-10-13 | Takeda Chem Ind Ltd | 徐放性マイクロスフィア、その製造法および用途 |
WO1998032423A1 (en) | 1997-01-29 | 1998-07-30 | Takeda Chemical Industries, Ltd. | Sustained-release microspheres, their production and use |
US5945126A (en) | 1997-02-13 | 1999-08-31 | Oakwood Laboratories L.L.C. | Continuous microsphere process |
GB9718986D0 (en) | 1997-09-09 | 1997-11-12 | Danbiosyst Uk | Controlled release microsphere delivery system |
US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
RU2230550C2 (ru) * | 1998-01-16 | 2004-06-20 | Такеда Кемикал Индастриз, Лтд. | Композиции длительного высвобождения, способ их получения и применение |
JPH11269094A (ja) | 1998-01-16 | 1999-10-05 | Takeda Chem Ind Ltd | 徐放性組成物、その製造法および用途 |
AU2745199A (en) | 1998-03-04 | 1999-09-20 | Takeda Chemical Industries Ltd. | Sustained-release preparation for aii antagonist, production and use thereof |
US6114495A (en) | 1998-04-01 | 2000-09-05 | Cargill Incorporated | Lactic acid residue containing polymer composition and product having improved stability, and method for preparation and use thereof |
US6565874B1 (en) | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
US6270802B1 (en) | 1998-10-28 | 2001-08-07 | Oakwood Laboratories L.L.C. | Method and apparatus for formulating microspheres and microcapsules |
CA2355186C (en) | 1998-12-15 | 2008-03-18 | Takeda Chemical Industries, Ltd. | Process for producing polymer |
SK342002A3 (en) | 1999-07-15 | 2002-05-09 | Takeda Chemical Industries Ltd | Sustained release compositions, process for producing the same and use thereof |
WO2001010414A1 (en) | 1999-08-04 | 2001-02-15 | Oakwood Laboratories L.L.C. | Slow release microspheres |
JP5046447B2 (ja) | 2000-08-07 | 2012-10-10 | 和光純薬工業株式会社 | 乳酸重合体及びその製造方法 |
US6824822B2 (en) | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
WO2002043766A1 (fr) | 2000-11-29 | 2002-06-06 | Takeda Chemical Industries, Ltd. | Compositions medicinales et leur procede de preparation |
AU2002221139A1 (en) | 2000-12-15 | 2002-06-24 | Takeda Chemical Industries Ltd. | Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof |
TWI225416B (en) | 2001-06-29 | 2004-12-21 | Takeda Chemical Industries Ltd | Sustained-release composition and process for producing the same |
AR034641A1 (es) | 2001-06-29 | 2004-03-03 | Takeda Pharmaceutical | Composicion de liberacion controlada y metodo para producirla |
WO2003055470A1 (fr) | 2001-12-26 | 2003-07-10 | Takeda Chemical Industries, Ltd. | Nouvelle microsphere et son procede de production |
US8088726B2 (en) * | 2002-06-25 | 2012-01-03 | Takeda Pharmaceutical Company Limited | Process for producing sustained-release composition |
US6803708B2 (en) * | 2002-08-22 | 2004-10-12 | Cdream Display Corporation | Barrier metal layer for a carbon nanotube flat panel display |
JP2008518881A (ja) | 2003-07-18 | 2008-06-05 | オークウッド ラボラトリーズ,エル.エル.シー. | 高分子組成物中の高分子の分子量低下、不純物形成およびゲル化の防止 |
WO2005009357A2 (en) | 2003-07-23 | 2005-02-03 | Pr Pharmaceuticals, Inc. | Controlled release compositions |
EP1670824A2 (de) * | 2003-09-24 | 2006-06-21 | Montana State University | Peptide und monoklonale antikörper gegen das norovirus |
TW200613012A (en) | 2004-07-02 | 2006-05-01 | Takeda Pharmaceuticals Co | Sustained-release composition, process for producing the same and use of the same |
CA2582096C (en) | 2004-10-01 | 2014-01-07 | Ramscor, Inc. | Conveniently implantable sustained release drug compositions |
EP1824460B1 (de) | 2004-11-10 | 2014-12-24 | Tolmar Therapeutics, Inc. | Stabilisiertes polymer-abgabesystem |
TWI481424B (zh) | 2006-12-18 | 2015-04-21 | Takeda Pharmaceutical | 緩釋性組成物及其製法 |
-
2007
- 2007-12-17 TW TW096148177A patent/TWI481424B/zh active
- 2007-12-17 EP EP07859925.5A patent/EP2094246B1/de active Active
- 2007-12-17 BR BRPI0720582-1A patent/BRPI0720582B1/pt active IP Right Grant
- 2007-12-17 WO PCT/JP2007/074617 patent/WO2008075762A1/en active Application Filing
- 2007-12-17 MX MX2009006653A patent/MX2009006653A/es active IP Right Grant
- 2007-12-17 EA EA200970600A patent/EA016176B1/ru not_active IP Right Cessation
- 2007-12-17 CA CA2671670A patent/CA2671670C/en not_active Expired - Fee Related
- 2007-12-17 NO NO20092662A patent/NO347209B1/no unknown
- 2007-12-17 CL CL200703658A patent/CL2007003658A1/es unknown
- 2007-12-17 KR KR1020097011993A patent/KR101522035B1/ko active IP Right Review Request
- 2007-12-17 ES ES07859925T patent/ES2791698T3/es active Active
- 2007-12-17 GE GEAP200711311A patent/GEP20125597B/en unknown
- 2007-12-17 US US12/312,751 patent/US8921326B2/en active Active
- 2007-12-17 CN CN2007800469578A patent/CN101563068B/zh active Active
- 2007-12-17 JP JP2009524632A patent/JP4564098B2/ja active Active
- 2007-12-17 AR ARP070105656A patent/AR064381A1/es not_active Application Discontinuation
- 2007-12-17 MY MYPI20092544A patent/MY148370A/en unknown
- 2007-12-17 NZ NZ577281A patent/NZ577281A/en unknown
- 2007-12-17 AU AU2007335406A patent/AU2007335406B2/en active Active
-
2008
- 2008-01-02 PE PE2008000035A patent/PE20081842A1/es active IP Right Grant
-
2009
- 2009-05-20 IL IL198845A patent/IL198845A/en active IP Right Grant
- 2009-05-20 TN TNP2009000197A patent/TN2009000197A1/fr unknown
- 2009-06-12 CR CR10867A patent/CR10867A/es unknown
- 2009-06-17 EC EC2009009439A patent/ECSP099439A/es unknown
- 2009-06-17 DO DO2009000144A patent/DOP2009000144A/es unknown
- 2009-06-17 MA MA32010A patent/MA31006B1/fr unknown
- 2009-06-18 CO CO09063558A patent/CO6180498A2/es not_active Application Discontinuation
-
2010
- 2010-06-07 JP JP2010130277A patent/JP5258844B2/ja active Active
-
2014
- 2014-11-19 US US14/547,467 patent/US9617303B2/en active Active
-
2017
- 2017-02-28 US US15/444,712 patent/US9713595B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY148370A (en) | Sustained-release composition and method for producing the same | |
US20190358332A1 (en) | Oral product with alginate composition of releasable substance | |
MXPA05012791A (es) | Formulacion sostenida que contiene dimeticona. | |
TW200608975A (en) | Pharmaceutical compositions | |
ATE424848T1 (de) | Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen | |
MY127797A (en) | 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol-containing pharmaceutical composition with slow release of active indgredient | |
WO2008157614A3 (en) | Sustained intraocular delivery of drugs from biodegradable polymeric microparticles | |
RU2004111596A (ru) | Офтальмические композиции в форме депо для периокулярного или субконъюнктивального введения | |
CA2468703A1 (en) | Controlled release polymeric compositions of bone growth promoting compounds | |
WO2008071407A3 (de) | Beschichtete pellets | |
ATE322513T1 (de) | Milchsäurepolymer und verfahren zu dessen herstellung | |
MY139606A (en) | Sustained-release composition and process for producing the same | |
WO2006053089A3 (en) | Methods and formulations for making pharmaceutical compositions containing bupropion | |
BRPI0606373A2 (pt) | composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma | |
UA97396C2 (ru) | Фармацевтическая композиция пролонгированного высвобождения, содержащая пасиреотид памоат в микрочастицах | |
TN2009000476A1 (en) | Slow release pharmaceutical composition made of microparticles | |
RU2007143556A (ru) | Композиции с пролонгированным высвобождением | |
WO2004078111A3 (en) | Extended release minocycline compositions and processes for their preparation | |
WO2007015270A3 (en) | Novel controlled release compositions of selective serotonin reuptake inhibitors | |
UA97125C2 (ru) | Композиция продолжительного высвобождения и способ ее получения | |
Tarawneh et al. | Development and characterization of k-carrageenan platforms as periodontal intra-pocket films | |
RU2011108370A (ru) | Жевательная композиция, включающая альгинат, бикарбонат и карбонат | |
NZ596275A (en) | Burst drug release compositions | |
TH120965B (th) | องค์ประกอบที่มีการปลดปล่อยแบบทยอยและวิธีการสำหรับการผลิตองค์ประกอบ | |
WO2006064321A3 (en) | Controlled release compositions of divalproex sodium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |